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Abstract: 
Worldwide, more than 80% of Nuclear Medicine procedures use a radiotracer produced 
through a 99Mo/99mTc generator - 99mTc – Technetium 99metastable. 
Most of the radiochemistry and equipments is optimized for this radioisotope characteristics 
already for more than 35 years, making it very difficult to replace. Worldwide production of 
99Mo is based essentially with only five Nuclear Reactors that are 
becoming obsolete and fragile with aging, shutting down more and more frequently as they 
approach the end of their shelf-life. 
Seeking for solutions, some Governments – and the EU – plan to build new dedicated Nuclear 
Reactor(s). Our work defends another option. 
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